The obesity epidemics in ESRD: From wasting to waist?

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 376-380

  Zoccali, Carmine ^a  

^a CNR   (Italy)

Author keywords

CKD; ESRD; Malnutrition; Metabolic syndrome; Obesity

Indexed keywords

FAT;

BODY MASS; DIALYSIS; DISEASE ASSOCIATION; ENERGY EXPENDITURE; HUMAN; INCIDENCE; KIDNEY FAILURE; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY MASS INDEX; DISEASE OUTBREAKS; EPIDEMIOLOGIC FACTORS; EUROPE; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; OBESITY; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; UNITED STATES;

EID: 58449128838     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn589     Document Type: Review

References (40)

1. Banegas JR, Lopez-Garcia E, Gutierrez-Fisac JL et al. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr 2003; 57: 201-208
2. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004; 59: 207-223
3. Wiseman M. The second world cancer research fund/American Institute for cancer research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253-256.
4. Metwally M, Ledger WL, Li TC. Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci 2008; 1127: 140-146
5. Plumb J, Brawer R, Brisbon N. The interplay of obesity and asthma. Curr Allergy Asthma Rep 2007; 7: 385-389
6. Greenfield V, Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2008; 24: 320-327
7. Garstang SV, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil 2006; 85: S2-S11
8. James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008; 263: 336-352
9. James WPT, Jackson-Leach R, Ni Mhurchu C et al. Overweight and obesity (high body mass index). In: Ezzati M et al. (ed). Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attribution to Selected Major Risk Factors. Geneva: World Health Organization, 2004, 497-596
10. Peeters A, Barendregt JJ, Willekens F et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24-32
11. Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 2008; 23: 2461-2466
12. Ritz E. Obesity and CKD: how to assess the risk? Am J Kidney Dis 2008; 52: 1-6
13. Ritz E. Metabolic syndrome and kidney disease. Blood Purif 2008; 26: 59-62
14. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
15. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
16. Kramer HJ, Saranathan A, Luke A et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006; 17: 1453-1459
17. De Mustert R, Snijder MB, van der Sman-de Beer F et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974
18. Johansen KL, Young B, Kaysen GA et al. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332
19. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005; 46: 489-500
20. Leavey SF, McCullough K, Hecking E et al. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394
21. Abdulla J, Kober L, Abildstrom SZ et al. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 2008; 29: 594-601
22. Kalantar-Zadeh K, Block G, Horwich T et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439-1444
23. Levin NW, Handelman GJ, Coresh J et al. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial 2007; 20: 586-592
24. Zoccali C, Testa A, Spoto B et al. Mendelian randomization: a new approach to studying epidemiology in ESRD. AmJ Kidney Dis 2006; 47: 332-341
25. K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000; 35: S1-S140
26. Fouque D, Vennegoor M, Ter WP et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22(Suppl 2): ii45-ii87
27. Kalantar-Zadeh K, Horwich TB, Oreopoulos A et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007; 10: 433-442
28. Romero-Corral A, Montori VM, Somers VK et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666-678
29. Franzosi MG. Should we continue to use BMI as a cardiovascular risk factor? Lancet 2006; 368: 624-625
30. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the 'beef '? Int J Obes (Lond) 2007; 31: 1552-1553
31. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002; 162: 2074-2079
32. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649
33. Thum T, Anker SD. Obesity and risk of myocardial infarction: the INTERHEART study. Lancet 2006; 367: 1051-1052
34. Snijder MB, van Dam RM, Visser M et al. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92
35. Beddhu S, Pappas LM, Ramkumar N et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372
36. Honda H, Qureshi AR, Axelsson J et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007; 86: 633-638
37. Sanches FM, Avesani CM, Kamimura MA et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008; 52: 66-73
38. Elsayed EF, Sarnak MJ, Tighiouart H et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008; 52: 29-38
39. Elsayed EF, Tighiouart H, Weiner DE et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 2008; 52: 49-57
40. Li PK, Kwan BC, Szeto CC et al. Metabolic syndrome in peritoneal dialysis patients. Nephrol Dial Transplant Plus 2008; 4: 206-214